© 2020 MJH Life Sciences™ and Modern Retina. All rights reserved.
Wet AMD
Regenxbio: Dosing of first patient in Phase 2 AAVIATE trial for wet AMD
September 09, 2020
Interim data update from first cohort using suprachoroidal delivery of RGX-314 expected by end of 2020
Deep learning algorithm proving accurate for AMD classification
September 01, 2020
Results of a prospective trial show the tool is ready for clinical use and potential deployment for remote telemedical use.
Contrast sensitivity shows potential for measuring visual function loss in early AMD
September 01, 2020
A study suggests this user-friendly platform may be useful as a supplemental visual function measure in patients with AMD.